Instituto de Biocomputación y Fisica de Sistemas Complejos (BIFI), BIFI-IQFR (CSIC) Joint Unit, Universidad de Zaragoza, 50018, Zaragoza, Spain.
UCIBIO, REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516, Caparica, Portugal.
Chemistry. 2018 Jun 12;24(33):8382-8392. doi: 10.1002/chem.201800701. Epub 2018 May 16.
The family of polypeptide N-acetylgalactosamine (GalNAc) transferases (GalNAc-Ts) orchestrates the initiating step of mucin-type protein O-glycosylation by transfer of GalNAc moieties to serine and threonine residues in proteins. Deficiencies and dysregulation of GalNAc-T isoenzymes are related to different diseases. Recently, it has been demonstrated that an inactive GalNAc-T2 mutant (F104S), which is not located at the active site, induces low levels of high-density lipoprotein cholesterol (HDL-C) in humans. Herein, the molecular basis for F104S mutant inactivation has been deciphered. Saturation transfer difference NMR spectroscopy experiments demonstrate that the mutation induces loss of binding to peptide substrates. Analysis of the crystal structure of the F104S mutant bound to UDP-GalNAc (UDP=uridine diphosphate), combined with molecular dynamics (MD) simulations, has revealed that the flexible loop is disordered and displays larger conformational changes in the mutant enzyme than that in the wild-type (WT) enzyme. F NMR spectroscopy experiments reveal that the WT enzyme only reaches the active state in the presence of UDP-GalNAc, which provides compelling evidence that GalNAc-T2 adopts a UDP-GalNAc-dependent induced-fit mechanism. The F104S mutation precludes the enzyme from achieving the active conformation and concomitantly binding peptide substrates. This study provides new insights into the catalytic mechanism of the large family of GalNAc-Ts and how these enzymes orchestrate protein O-glycosylation.
多肽 N-乙酰半乳糖胺(GalNAc)转移酶(GalNAc-Ts)家族通过将 GalNAc 部分转移到蛋白质中的丝氨酸和苏氨酸残基上来协调粘蛋白型蛋白 O-糖基化的起始步骤。GalNAc-T 同工酶的缺乏和失调与不同的疾病有关。最近,已经证明位于活性部位之外的无活性 GalNAc-T2 突变体(F104S)在人类中诱导低水平的高密度脂蛋白胆固醇(HDL-C)。在此,解析了 F104S 突变体失活的分子基础。饱和转移差异 NMR 光谱实验表明,该突变导致与肽底物结合的丧失。结合分子动力学(MD)模拟,对 F104S 突变体与 UDP-GalNAc(UDP=尿苷二磷酸)结合的晶体结构的分析表明,柔性环无序,并且在突变酶中显示出比野生型(WT)酶更大的构象变化。 F NMR 光谱实验表明,WT 酶仅在存在 UDP-GalNAc 的情况下才达到活性状态,这有力地证明了 GalNAc-T2 采用 UDP-GalNAc 依赖性诱导契合机制。F104S 突变使酶无法达到活性构象并同时结合肽底物。这项研究为 GalNAc-Ts 的大家族的催化机制以及这些酶如何协调蛋白 O-糖基化提供了新的见解。